FDA
-
-
-
-
-
-
-
NextCure Presents Positive SIM0505 Phase 1 Dose Escalation Data in Patients with Gynecologic Cancers at ASCO 2026
-
-
-
-
-
-
-
NextCure reports preclinical data on bone disease treatment
-
-
-
-
-
-
-
NextCure Inc. (NXTC) Announces Acceptance of IND Application for LNCB74
-
-
-
-
-
-
-
NextCure Provides Update and Reports Third Quarter 2022 Financial Results
-
-
-
-
-
-
-
NextCure Announces New Appointments to its Board of Directors
-
-
-
-
-
-
-
NextCure Reports First Quarter 2020 Financial Results
-
-
-
-
-
-
-
NextCure Reports Third Quarter 2019 Financial Results
-
327,775 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

